The urgent need for randomized controlled trials in pregnant women with antiphospholipid antibodies—protecting women through research

IntroductionObstetric antiphospholipid syndrome (OAPS) is an autoimmune disorder associated with pregnancy morbidity, including recurrent pregnancy loss, preeclampsia and fetal growth restriction. Despite standard of care (SoC) with low-dose aspirin (LDA) and low-molecular-weight heparin (LMWH), 20%...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Christine Graversgaard Adams, Jullie Rudnicki, Berit Fabricius Petersen, Søren Jacobsen, Karen Schreiber
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2026-02-01
Schriftenreihe:	Frontiers in Lupus
Schlagworte:	antiphospholipid antibodies obstetric APS randomized controlled trials refractory obstetrical APS evidence gap
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/flupu.2026.1747204/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!